Latest Artificial heart Stories

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Artificial Organs - Worldwide Market Challenges & Opportunities http://www.reportlinker.com/p0164217/Artificial-Organs---Worldwide-Market-Challenges--Opportunities.html With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and minimizing...

A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy for many of the more than 5 million Americans who suffer from heart failure.A research team led by a University of Louisville cardiac surgeon published data to support these conclusions in the November 17, 2009 Online First edition of the New England Journal of Medicine. The results were...

Study highlights: -- Continuous flow heart pump improved survival better than pulsating pump for heart failure patients ineligible for transplant. -- The new, continuous flow left ventricular assist device is smaller, quieter and more durable than pulsating models. ORLANDO, Fla., Nov. 17 /PRNewswire-USNewswire/ -- A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile...

Teen enjoys normal activities outside of hospital while awaiting donor heartTexas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions. The patient, 16-year-old Francisco "Frank" De Santiago, who was implanted with a mechanical heart pump called the HeartMate II on May 19, 2009, was discharged on Oct. 29, 2009."This is a promising...

BERLIN, November 10 /PRNewswire/ -- The 500th patient to receive an INCOR(R) ventricular assist device was implanted on 20 October 2009 at the German Heart Institute Berlin. The 39-year-old male patient was suffering from dilative cardiomyopathy, a disease that causes the heart to enlarge and the heart muscle to weaken to the extent that it cannot provide enough blood flow through the body. The cardiomyopathy progressed to a stage where conventional treatment was no longer...

UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant.Called a left-ventricular assist device (LVAD), its purpose is to help a patient's weakened heart pump blood throughout the body. For Mr. LeBlanc, it will help his ailing heart continue to pump until the Irving resident receives a new heart. UT Southwestern...

FRAMINGHAM, Mass. and SYDNEY, Oct. 5 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the number of clinical sites participating in its U.S. bridge-to-transplant trial, known as the ADVANCE trial. Pursuant to the FDA approval, HeartWare will be permitted to enroll a total of 40 clinical sites for the purposes of evaluating the Company's Ventricular Assist...

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. World Ventricular Assist Devices Market http://www.reportlinker.com/p0109889/World-Ventricular-Assist-Devices-Market.html This report analyzes the worldwide markets for Ventricular Assist Devices in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for the period of 2006 through...

NEW YORK and BEIRUT, Sept. 3 /PRNewswire/ -- A medical team at the American University of Beirut Medical Center (AUBMC) has successfully performed the first artificial heart implant in Lebanon, saving the life of a 37-year-old man suffering from terminal heart failure. Led by two AUB doctors, the six-hour operation, which took place on August 28, 2009, was deemed a success after the patient survived the first critical 72 hours and showed improvements in all his vital signs. The artificial...

THE WOODLANDS, Texas, September 1 /PRNewswire/ -- Berlin Heart Inc. reported today that it has completed enrollment in Cohort 1 of the Berlin Heart EXCOR(R) Pediatric IDE Study after having received unconditional approval of the study from the FDA in November 2008. The Principal Investigator, Dr. Charles Fraser, Chief of Congenital Heart Surgery at Texas Children's Hospital and Professor of Surgery and Pediatrics at Baylor College of Medicine said, "We are very pleased with the...